2.6100
+0.0600
+(2.35%)
At close: April 9 at 4:00:02 PM EDT
2.6801
+0.07
+(2.69%)
Pre-Market: 8:18:51 AM EDT
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
97,190
81,637
116,191
149,544
Total Liabilities Net Minority Interest
14,241
11,898
9,848
9,127
Total Equity Gross Minority Interest
82,949
69,739
106,343
140,417
Total Capitalization
82,949
69,739
106,343
140,417
Preferred Stock Equity
--
--
--
1
Common Stock Equity
82,949
69,739
106,343
140,416
Capital Lease Obligations
1,523
2,149
2,715
3,119
Net Tangible Assets
82,949
69,739
106,343
140,417
Working Capital
81,626
66,972
103,476
139,568
Invested Capital
82,949
69,739
106,343
140,416
Tangible Book Value
82,949
69,739
106,343
140,416
Total Debt
1,523
2,149
2,715
3,119
Share Issued
66,524.1820
44,677
44,677
41,963.7040
Ordinary Shares Number
66,524.1820
44,677
44,677
41,963.7040
12/31/2021 - 7/27/2004
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
IMUX Immunic, Inc.
0.9246
+3.31%
RVPH Reviva Pharmaceuticals Holdings, Inc.
0.5821
+9.83%
VSTM Verastem, Inc.
5.28
+13.67%
ALDX Aldeyra Therapeutics, Inc.
1.9400
+1.04%
MIST Milestone Pharmaceuticals Inc.
0.7233
+10.78%
SLS SELLAS Life Sciences Group, Inc.
1.1200
+7.69%
TRVI Trevi Therapeutics, Inc.
5.40
+1.89%
MESO Mesoblast Limited
11.08
+10.47%
TERN Terns Pharmaceuticals, Inc.
2.3000
+12.20%
PDSB PDS Biotechnology Corporation
1.0000
+6.94%